JP Morgan Chase
RGNX icon

JP Morgan Chase’s Regenxbio RGNX Stock Holding History

JP Morgan Chase’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,400
Closed -$513K – 5852
2019
Q3 		$513K Buy
+14,400
New +$583K ﹤0.01% 4161
2018
Q2 		– Sell
-10,500
Closed -$313K – 5667
2018
Q1 		$313K Sell
10,500
-36,200
-78% -$1.05M ﹤0.01% 4203
2017
Q4 		$1.55M Buy
+46,700
New +$1.41M ﹤0.01% 3469

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase's RGNX Position: Q2 2026 in Review

JP Morgan Chase reduced its Regenxbio (RGNX) stake by 36% in Q2 2026, selling an estimated $10.5M and leaving 2,214,169 shares worth $26.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1987.

JP Morgan Chase first reported a position in RGNX in Q3 2015 and has held it in 44 quarters since. The position peaked at $174M in Q3 2021. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • JP Morgan Chase held 2,214,169 shares of Regenxbio worth $26.2M as of Q2 2026.
  • JP Morgan Chase sold 1,269,631 Regenxbio shares in Q2 2026, an estimated $10.5M.
  • Regenxbio made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1987 holding.
  • JP Morgan Chase first reported a position in Regenxbio in Q3 2015 and has held it in 44 quarters since.
  • JP Morgan Chase's Regenxbio position peaked at $174M in Q3 2021.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.